Voyager Therapeutics, Inc. Operating Lease Liability
Voyager Therapeutics, Inc. (VYGR) had Operating Lease Liability of $32.57 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $32.57M.
- 2026-03-31: Operating Lease, Liability $34.57M.
- 2025-12-31: Operating Lease, Liability $36.50M.
- 2025-09-30: Operating Lease, Liability $38.37M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $32.57M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $34.57M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $36.50M 10-K · filed 2026-03-09 |
| 2025-09-30 | $38.37M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $40.20M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $42.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $43.73M 10-K · filed 2025-03-11 |
| 2021-12-31 | $44.18M 10-K · filed 2022-03-08 |
| 2021-09-30 | $45.26M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $45.72M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $46.74M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $47.61M 10-K · filed 2021-02-25 |
| 2020-09-30 | $31.80M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $32.60M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $33.39M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $34.17M 10-K · filed 2020-03-03 |
| 2019-09-30 | $34.81M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $35.45M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |